Results 301 to 310 of about 2,420,770 (348)
Protection Against Type 1 Diabetes Development in Mice With 4E-BP2 Deletion. [PDF]
Pita-Grisanti V +7 more
europepmc +1 more source
"What is it like to live with a CGM?": A qualitative study on type 1 diabetes patients' experiences. [PDF]
Kang JH, Yang Y, Yeom S.
europepmc +1 more source
(TCRαβ<sup>+</sup>) Double-Negative T Cells in Type 1 Diabetes Mellitus. [PDF]
Poddighe D +6 more
europepmc +1 more source
Preclinical Diagnosis of Type 1 Diabetes: Reality or Utopia. [PDF]
Marakhovskaya TA +26 more
europepmc +1 more source
B Lymphocytes Impede Tregs to Erode Islet Tolerance in Type 1 Diabetes. [PDF]
Wilson CS, Stocks BT, Falk AC, Moore DJ.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Lancet, 2006
Type 1 diabetes accounts for only about 5-10% of all cases of diabetes; however, its incidence continues to increase worldwide and it has serious short-term and long-term implications. The disorder has a strong genetic component, inherited mainly through the HLA complex, but the factors that trigger onset of clinical disease remain largely unknown ...
Andrea Dann, Urban, Margaret, Grey
+6 more sources
Type 1 diabetes accounts for only about 5-10% of all cases of diabetes; however, its incidence continues to increase worldwide and it has serious short-term and long-term implications. The disorder has a strong genetic component, inherited mainly through the HLA complex, but the factors that trigger onset of clinical disease remain largely unknown ...
Andrea Dann, Urban, Margaret, Grey
+6 more sources
Annals of Internal Medicine, 2022
Type 1 diabetes mellitus (T1DM) is an endocrine disorder in which pancreatic β cells stop producing insulin, typically due to autoimmune destruction. This results in hyperglycemia and ketosis; thus, insulin replacement is vital to management. Incidence peaks in puberty and early adulthood, but onset can occur at any age.
openaire +2 more sources
Type 1 diabetes mellitus (T1DM) is an endocrine disorder in which pancreatic β cells stop producing insulin, typically due to autoimmune destruction. This results in hyperglycemia and ketosis; thus, insulin replacement is vital to management. Incidence peaks in puberty and early adulthood, but onset can occur at any age.
openaire +2 more sources
Nature Reviews Disease Primers, 2017
Type 1 diabetes mellitus (T1DM), also known as autoimmune diabetes, is a chronic disease characterized by insulin deficiency due to pancreatic β-cell loss and leads to hyperglycaemia. Although the age of symptomatic onset is usually during childhood or adolescence, symptoms can sometimes develop much later.
Anastasia, Katsarou +8 more
openaire +2 more sources
Type 1 diabetes mellitus (T1DM), also known as autoimmune diabetes, is a chronic disease characterized by insulin deficiency due to pancreatic β-cell loss and leads to hyperglycaemia. Although the age of symptomatic onset is usually during childhood or adolescence, symptoms can sometimes develop much later.
Anastasia, Katsarou +8 more
openaire +2 more sources
Current Diabetes Reports, 2005
Predicting type 1 diabetes mellitus (T1DM) is a prerequisite for disease prevention. Prediction is currently performed on three levels, which include the genetic susceptibility for disease, the identification of preclinical T1DM by way of circulating islet autoantibodies, and the use of metabolic tests to stage preclinical disease into late or early ...
Peter, Achenbach +2 more
openaire +2 more sources
Predicting type 1 diabetes mellitus (T1DM) is a prerequisite for disease prevention. Prediction is currently performed on three levels, which include the genetic susceptibility for disease, the identification of preclinical T1DM by way of circulating islet autoantibodies, and the use of metabolic tests to stage preclinical disease into late or early ...
Peter, Achenbach +2 more
openaire +2 more sources

